NCT07434609 2026-02-25
Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors
Nanolattix Biotechnology Co., Ltd.
Phase 1 Not yet recruiting
Clinical Trials
3 trialsNCT07163325 2025-09-09
EP102 Safety and Efficacy in METTL3 Modulation in Advanced Solid Tumors
Epics Therapeutics
Phase 1 Recruiting
NCT06527300 2025-01-24
A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer
Zhejiang Wenda Pharma Technology LTD.
Phase 2 Recruiting